HC Wainwright & Co. Maintains Buy on Renalytix, Lowers Price Target to $15

HC Wainwright & Co. analyst Yi Chen maintains Renalytix (NASDAQ:RNLX) with a Buy and lowers the price target from $30 to $15.

HC Wainwright & Co. analyst Yi Chen maintains Renalytix (NASDAQ:RNLX) with a Buy and lowers the price target from $30 to $15.

Total
0
Shares
Related Posts